idarubicin has been researched along with glycosides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horton, D; Khare, A | 1 |
| Bhatnagar, R; Dahiya, P; Gl, B; Grover, A; Gupta, M; Rajput, R; Thakur, JK | 1 |
2 other study(ies) available for idarubicin and glycosides
| Article | Year |
|---|---|
Anthracycline glycosides of 2,6-dideoxy-2-fluoro-alpha-L-talopyranose.
Topics: Anthracyclines; Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Glycosides; Humans; Idarubicin; Neoplasms | 2006 |
Structure-based drug repurposing to inhibit the DNA gyrase of Mycobacterium tuberculosis.
Topics: Adenosine Triphosphatases; Antitubercular Agents; Circular Dichroism; DNA Gyrase; Doxorubicin; Drug Design; Drug Repositioning; Epirubicin; Glycosides; Idarubicin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Surface Plasmon Resonance; Topoisomerase II Inhibitors | 2020 |